Excellent point. And we were expected to sell in mass at .28. I wonder when .40 will be seen as having been cheap?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025